Título:
|
Pancreatic autoantibodies and CD14+CD16+ monocytes subset are associated with the impairment of ß-cell function after simultaneous pancreas-kidney transplantation
|
Autores:
|
Rodelo-Haad, Cristian ;
Agüera, María Luisa ;
Carmona, Andrés ;
Navarro, María Dolores ;
Carracedo, Julia ;
Rodríguez-Benot, Alberto ;
Aljama, Pedro
|
Tipo de documento:
|
texto impreso
|
Editorial:
|
Public Library of Science, 2019-02-22
|
Dimensiones:
|
application/pdf
|
Nota general:
|
cc_by
info:eu-repo/semantics/openAccess
|
Idiomas:
|
|
Palabras clave:
|
Estado = Publicado
,
Materia = Ciencias Biomédicas: Medicina: Gastroenterología y hepatología
,
Materia = Ciencias Biomédicas: Biología: Microbiología
,
Tipo = Artículo
|
Resumen:
|
Pancreatic autoantibodies (AAb) has been associated with a worse pancreas graft survival after simultaneous pancreas-kidney transplantation (SPK). However, due to the variable time for AAb to become positive and the lack of early biomarkers suggesting such autoimmune activation, the mechanisms leading ß-cell destruction remain uncertain. The present study aimed to evaluate the association between post-transplant AAb and the functional impairment of the pancreatic ß-cell and also the association of such AAb with inflammation after SPK. In a longitudinal study, we analyzed the impact of post-transplant glutamic acid decarboxylase (GAD-65) and the insulinoma-associated autoantigen 2 (IA-2) AAb on pancreas graft function. Serum Hb1Ac and C-peptide (C-pep) were longitudinally compared between a group with positive posttransplant AAb (AAb+; n = 40) and another matched group with negative AAb (AAb-; n = 40) until the fifth year following seroconversion. In the cross-sectional analysis, we further evaluated the systemic signatures of inflammation by measuring pro-inflammatory CD14+CD16+ monocytes by flow-cytometry and interleukin 17-A serum levels in 38 SPK recipients and ten healthy controls. In the longitudinal study, patients with AAb+ showed higher levels of Hb1Ac (p
|
En línea:
|
https://eprints.ucm.es/57162/1/Carracedo-DGFM-Pancreatic-autoantibodies.pdf
|